O Lucro Antes De Impostos Alterar Data
AstraZeneca USD 3.91B 1.28B 2026-03
Genmab DKK 55M 427M 2025-12
GlaxoSmithKline GBP 2.14B 919M 2026-03
GRIFOLS EUR 190.51M 20.03M 2025-06
Hikma Pharmaceutical USD 147.5M 3.5M 2025-06
Lakefront Biotherapeutics EUR 13.96M 769.2M 2026-03
Qiagen NV USD 109.17M 25.56M 2025-12
UCB EUR 789M 427M 2025-06